Javascript must be enabled to continue!
Chronic endothelin‐1 infusion causes adipocyte hyperplasia in rats
View through CrossRef
ObjectiveThe aim of this study was to investigate the regulatory mechanism of endothelin‐1 (ET‐1), an endothelium‐derived vasoconstrictor, on adipogenesis in vitro and in vivo.Methods3T3‐L1 preadipocytes were used to explore the mechanisms mediating ET‐1 actions on preadipocyte proliferation and adipocyte differentiation. To investigate the in vivo effect of ET‐1, male Sprague‐Dawley rats were infused with ET‐1 or saline for 4 weeks via intraperitoneally implanted osmotic pumps, and the fat pad weight and adipocyte size of adipose tissues were measured.ResultsET‐1 stimulated preadipocyte proliferation and increased the cell number at the mitotic clonal expansion stage of adipocyte differentiation via the endothelin A receptor (ETAR) and activation of the protein kinase C (PKC) pathway. ET‐1, via ETAR, inhibited adipocyte differentiation partially through an ERK‐dependent pathway. Furthermore, no significant difference in the body weight and fat pad weight was observed in either ET‐1‐ or saline‐infused rats. Compared with saline‐infused rats, the adipocyte cell number was significantly increased but the adipocyte size was significantly decreased in ET‐1‐infused rats.ConclusionsChronic ET‐1 infusion increased the number of small adipocytes without the change of white adipose tissue mass in rats, which were associated with ET‐1‐stimulated preadipocyte proliferation, but not ET‐1‐suppressed adipocyte differentiation.
Title: Chronic endothelin‐1 infusion causes adipocyte hyperplasia in rats
Description:
ObjectiveThe aim of this study was to investigate the regulatory mechanism of endothelin‐1 (ET‐1), an endothelium‐derived vasoconstrictor, on adipogenesis in vitro and in vivo.
Methods3T3‐L1 preadipocytes were used to explore the mechanisms mediating ET‐1 actions on preadipocyte proliferation and adipocyte differentiation.
To investigate the in vivo effect of ET‐1, male Sprague‐Dawley rats were infused with ET‐1 or saline for 4 weeks via intraperitoneally implanted osmotic pumps, and the fat pad weight and adipocyte size of adipose tissues were measured.
ResultsET‐1 stimulated preadipocyte proliferation and increased the cell number at the mitotic clonal expansion stage of adipocyte differentiation via the endothelin A receptor (ETAR) and activation of the protein kinase C (PKC) pathway.
ET‐1, via ETAR, inhibited adipocyte differentiation partially through an ERK‐dependent pathway.
Furthermore, no significant difference in the body weight and fat pad weight was observed in either ET‐1‐ or saline‐infused rats.
Compared with saline‐infused rats, the adipocyte cell number was significantly increased but the adipocyte size was significantly decreased in ET‐1‐infused rats.
ConclusionsChronic ET‐1 infusion increased the number of small adipocytes without the change of white adipose tissue mass in rats, which were associated with ET‐1‐stimulated preadipocyte proliferation, but not ET‐1‐suppressed adipocyte differentiation.
Related Results
The Influence of Subcutaneous and Visceral Adipocyte Geometries on Metabolic Parameters and Metabolic Regulating Hormones in Obese and Non-Obese Subjects
The Influence of Subcutaneous and Visceral Adipocyte Geometries on Metabolic Parameters and Metabolic Regulating Hormones in Obese and Non-Obese Subjects
Adipose tissue plays a pivotal role in endocrine and metabolic homeostasis. This study aimed to compare subcutaneous and visceral adipocyte measurements, including area, shortest d...
Modern approaches to infusion therapy in pediatrics and chemotherapy
Modern approaches to infusion therapy in pediatrics and chemotherapy
Background. Systems for intravenous administration of blood products and drugs are divided into the systems for transfusion (pore diameter – 114-200 μm) and systems for infusion (p...
Voiding symptom severity varies independently from non-adrenergic prostate smooth muscle contractions in patients undergoing surgery for benign prostatic hyperplasia
Voiding symptom severity varies independently from non-adrenergic prostate smooth muscle contractions in patients undergoing surgery for benign prostatic hyperplasia
BackgroundResistance of voiding symptoms to α1-blockers in benign prostatic hyperplasia (BPH) has been provisionally explained by non-adrenergic prostate smooth muscle contraction....
Trehalose increases jejunum cytoplasmic lipid droplets and suppresses adipocyte hypertrophy
Trehalose increases jejunum cytoplasmic lipid droplets and suppresses adipocyte hypertrophy
Abstract
Background: Trehalose is a functional disaccharide that has anti-metabolic activities such as suppression of adipocyte hypertrophy in mice and alleviation of impai...
Effects of 5,5′-diphenylhydantoin on the thyroid status in rats
Effects of 5,5′-diphenylhydantoin on the thyroid status in rats
Schröder-van der Elst JP, van der Heide D, van der Bent C, Kaptein E, Visser TJ, DiStefano JJ, Effects of 5,5′diphenylhydantoin on the thyroid status in rats. Eur J Endocrinol 1996...
Endothelial dysfunction and features of nociceptive sensitivity in patients with microvascular angina
Endothelial dysfunction and features of nociceptive sensitivity in patients with microvascular angina
Abstract
Funding Acknowledgements
Type of funding sources: Public Institution(s). Main funding source(s): фГБ ОУ ВО СЗГМУ им. И....
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Implementation and Pilot Evaluation of A Pharmacist-Led Optimization Tool for Subcutaneous Immune Globulin Administration in the Home Setting
Implementation and Pilot Evaluation of A Pharmacist-Led Optimization Tool for Subcutaneous Immune Globulin Administration in the Home Setting
Background
This study aimed to develop a standardized method and timeline for home infusion
pharmacists to assess subcutaneous immune globulin (SCIG) regimens and perform
intervent...

